№ lp_1_2_57904
TRIMBOW is a fixed-dose combination therapy for the maintenance treatment of moderate to severe COPD, compared with Trelegy Ellipta, assessing clinical outcomes and cost-effectiveness.
Year: 2020
Region / city: Australia
Topic: Medical Submission for Pharmaceutical Product
Document Type: Submission
Organization / Institution: Chiesi Australia Pty Ltd
Author: Chiesi Australia Pty Ltd
Target Audience: Medical professionals, regulatory authorities
Period of validity: Not specified
Approval Date: June 24, 2020
Date of changes: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.